Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 16, 2025
FAP Expression in Renal Tumors Assessed by [<sup>68</sup>Ga]Ga-FAPI-46 PET Imaging and FAP Immunohistochemistry: A Case Series of Six Patients from the Prospective Exploratory Trial NCT04147494Adrien Holzgreve, Lena M Unterrainer, Kimberly Flores, et al.
Diagnostics (Basel, Switzerland)|February 25, 2022
Detection of Splenic Tissue Using <sup>99m</sup>Tc-Labelled Denatured Red Blood Cells Scintigraphy-A Quantitative Single Center AnalysisAdrien Holzgreve, Friederike Völter, Astrid Delker, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 25, 2026
Metformin and renal dosimetry in patients undergoing [<sup>177</sup>Lu]Lu-PSMA therapy: reduced kidney absorbed dose without impact on tumor dosimetrySophie Carina Siegmund, Astrid Delker, Liam Widjaja, et al.
Biomedicines|November 25, 2023
PSMA-Expression Is Highly Associated with Histological Subtypes of Renal Cell Carcinoma: Potential Implications for Theranostic ApproachesVinh Ngoc Bui, Lena M Unterrainer, Matthias Brendel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 13, 2026
Systematic evaluation of response and adverse events in mCRPC patients treated with different combinations of [<sup>225</sup>Ac]Ac/[<sup>177</sup>Lu]Lu-PSMA-therapyGabriel T Sheikh, Sophie C Siegmund, Liam Widjaja, et al.
EJNMMI Research|March 4, 2025
RECIP 1.0 + PSA for response assessment in mCRPC patients treated with <sup>225</sup>Ac / <sup>177</sup>Lu PSMA combination therapyGabriel T Sheikh, Astrid Delker, Mathias J Zacherl, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 21, 2024
Image-based dosimetry for [<sup>225</sup>Ac]Ac-PSMA-I&T therapy and the effect of daughter-specific pharmacokineticsGrigory Liubchenko, Guido Böning, Mathias Zacherl, et al.
EJNMMI Research|October 30, 2023
Effects of novel androgen receptor signaling inhibitors on PSMA PET signal intensity in patients with castrate-resistant prostate cancer: a prospective exploratory serial imaging studyIda Sonni, Andrei Gafita, Lena M Unterrainer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 5, 2025
[<sup>99m</sup>Tc]Tc-antigranulocyte scintigraphy for prediction of bone marrow reserve prior to radioligand therapy in patients with metastatic castration resistant prostate cancerSophie Carina Kunte, Astrid Delker, Adrien Holzgreve, et al.
Diagnostics (Basel, Switzerland)|August 28, 2025
Prognostic Value of Automated Bone Scan Index (aBSI) in Patients with mCRPC Undergoing Three vs. Six Cycles of <sup>223</sup>Ra TherapySophie C Siegmund, Harun Ilhan, Antonia Gerull, et al.
Pageof 7